FDA Approves First Nasal Spray for Treatment of Anaphylaxis
Today, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life-threatening...
FDA Approves Nasal Spray Influenza Vaccine for Self- or ...
Sep 20, 2024 · FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the …
FDA Approves Nasal Spray for Depression - Newsweek
1 day ago · The FDA has now expanded its approval to include the standalone use of the nasal spray for adults with treatment-resistant major depressive disorder. A stock photo showing a …
FDA approves first standalone nasal spray for severe depression
1 day ago · Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive …
FDA approves new nasal spray medication for treatment ...
The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried...
FDA Approves Spravato Nasal Spray for Treatment-Resistant ...
1 day ago · WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with …
FDA allows standalone use of nasal spray antidepressant ...
1 day ago · The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for …